BCDA Setting up for a Long?

NASDAQ:BCDA   BioCardia, Inc.
I'm adding a new stock to my watchlist. $BCDA has Market Cap of 36.28 M and an Enterprise Value of 31.32 M. It has 31.3% insider ownership with the management buying shares each month since September 2022 through December 2022. They create cellular therapeutics for cardiovascular diseases. Their revenue has been growing 11% per year over the past 5 years. Price project is now set to $6.22 (344%) move in the future.

I see many are trapped in the $3.69 area.

Do your own due diligence not stock advice. Just my thoughts.